The Kansai Life Science Accelerator Program (KLSAP) was launched in 2020 to support life science startups to expand their business overseas by providing the opportunity to participate in the mentoring sessions by US expertise in the life science field.
On September 13th, the Kansai Life Science Accelerator Program 2024 pitch event was held in Kobe. There were many excellent applicants, but in the end 3 startups were selected to participate in the KLSAP2024 Accelerator Program starting from October 2024. In addition, the audience voted for the most impressive startup of the day and awarded the Audience Award.
The 3-month program, which includes five bi-weekly customized advisory sessions and two presentation brush up sessions will be coordinated by BioLabs. The program will conclude in January 2025 with a Demo Day where the 3 companies will present their innovative technologies to potential alliance, development, and investment partners in the event hosted by BioLabs in US.
【KLSAP2024 Accelerator Program Participating Startups】
*Alphabetical order
| Enterobiome Inc. | Jaegu Seo, CEO |
| LinqMed Inc. | Yukie Yoshii, Ph.D., President & CEO |
| Physiologas Technologies Inc. | Kazuyoshi Miyawaki, CEO |
【KLSAP2024 Audience Award】
*Alphabetical order
| LinqMed Inc. | Yukie Yoshii, Ph.D., President & CEO |
The organizers and sponsors hope they will take full advantage of this program. Congratulations and Good luck on your upcoming journey !
【About BioLabs】
https://www.biolabs.io/BioLabs, is a Cambridge, Massachusetts, USA based internationally known innovation laboratory platform operating a network of shared lab and office workspaces for life science start-ups. as well as entrepreneur support programs. BioLabs currently operates 16 coworking lab facilities in major biotech clusters in the USA, Europe, and Japan, supporting life sciences entrepreneurs around the world.
【Kansai Life Science Accelerator Program 2024 Organizers and Supporters】
- Organizer：
- Foundation for Biomedical Research and Innovation at Kobe, City of Kobe
- Sponsor：
- Bayer Yakuhin Ltd., Celltrion, Inc., Sysmex Corporation, AstraZeneca K.K.,
Kyoto University Office of Institutional Advancement and Communications - Supporting Organization:
- Biocommunity Kansai, Hyogo Prefectural Government,
Kansai Innovation initiative, Kyoto Research Park Corp.,
Life Science Innovation Network Japan (LINK-J),
NPO Kinki Bio-Industry Development Organization,
Osaka Prefectural Government, Sumitomo Mitsui Banking Corporation - Support：
- BioLabs Global